The Effects of Sevelamer Carbonate on Diabetic Nephropathy
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 117 participants.
Also called NCT01493050
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 117 participants
- Sponsor
- Gary Striker
- Registry
-
NCT01493050
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT01493050. Randomized; quadruple masking; primary purpose treatment. Start 2012-02 (registry gives no type); primary completion 2013-12 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Effects of Sevelamer Carbonate on Diabetic Nephropathy
- Condition
- Diabetic Nephropathy
- Intervention (Drug)
- Sevelamer Carbonate
- Intervention (Drug)
- calcium carbonate
- Lead sponsor
- Gary Striker
Record details
- Record id
cardio:ct-nct01493050- Content hash
53d077808d5b4f8d3352e3b3cd51d1ea98d40304433193ecfd3bffabb6eef588